PUBLIC COMPANY
saveBayer AG
updated 21d ago
Bayer AG is a German multinational pharmaceutical and biotechnology company and is one of the largest pharmaceutical companies and biomedical companies in the world. Headquartered in Leverkusen, Bayer's areas of business include pharmaceuticals, consumer healthcare products, agricultural chemicals, seeds and biotechnology products. The company is a component of the EURO STOXX 50 stock market index.
community read0 votes
🐶 often sniffed alongside
top 6pipeline
10
marketed
5
phase 3
1
catalysts ytd
8
approvals ytd
2
recalls ytd
0
Pipeline(10)
pipeline depth10 products
1Phase 12Phase 21Phase 35Marketed1Unknown
Marketed
Kyleena
Female Contraception
Marketedantihemophilic factor (recombinant)
Hemophilia A (Factor VIII Deficiency)
Marketedfinerenone
Chronic Kidney Disease (Chronic Renal Failure)
Mineralocorticoid receptor
Marketedregorafenib
Recurrent Glioblastoma Multiforme (GBM)
Discoidin domain-containing receptor 2Ephrin type-A receptor 2
Marketedsevabertinib
Non-Small Cell Lung Cancer
Phase 3asundexian
Ischemic Stroke
Phase 2BAY-3401016
Alport Syndrome
Phase 2emodepside
Onchocerciasis (River Blindness)
Phase 1Bapotulimab
Head And Neck Squamous Cell Carcinoma (HNSC)
drugALEVE
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
Where Bayer AG is staffing up — a leading indicator of pipeline and commercial priorities.
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that